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Abstract
Background: Leishmania infantum is the causative agent of visceral and cutaneous leishmaniasis in the Mediterranean
region, South America, and China. MON-1 L. infantum is the predominating zymodeme in all endemic regions, both in
humans and dogs, the reservoir host. In order to answer important epidemiological questions it is essential to discriminate
strains of MON-1.
Methodology/Principal Findings: We have used a set of 14 microsatellite markers to analyse 141 strains of L. infantum
mainly from Spain, Portugal, and Greece of which 107 strains were typed by MLEE as MON-1. The highly variable
microsatellites have the potential to discriminate MON-1 strains from other L. infantum zymodemes and even within MON-1
strains. Model- and distance-based analysis detected a considerable amount of structure within European L. infantum. Two
major monophyletic groups—MON-1 and non-MON-1—could be distinguished, with non-MON-1 being more polymorphic.
Strains of MON-98, 77, and 108 were always part of the MON-1 group. Among MON-1, three geographically determined and
genetically differentiated populations could be identified: (1) Greece; (2) Spain islands–Majorca/Ibiza; (3) mainland Portugal/
Spain. All four populations showed a predominantly clonal structure; however, there are indications of occasional
recombination events and gene flow even between MON-1 and non-MON-1. Sand fly vectors seem to play an important
role in sustaining genetic diversity. No correlation was observed between Leishmania genotypes, host specificity, and
clinical manifestation. In the case of relapse/re-infection, only re-infections by a strain with a different MLMT profile can be
unequivocally identified, since not all strains have individual MLMT profiles.
Conclusion: In the present study for the first time several key epidemiological questions could be addressed for the MON-1
zymodeme, because of the high discriminatory power of microsatellite markers, thus creating a basis for further
epidemiological investigations.
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Introduction
Visceral leishmaniasis (VL) caused by Leishmania infantum
(synonym L. chagasi, [1]) is a public-health problem in most
countries bordering the Mediterranean, China and South America.
Currently, the epidemiology of Mediterranean VL is changing.
Increasing incidence [2] and a shift in the bulk of cases from
children to adults [3,4], related to the emergence of HIV, has been
reported. Since 1985 up to 80% of the cases have occurred in
immunocompromised adults [5,6]. Leishmania/HIV co-infections
have become increasingly frequent in Southern Europe, particularly
in Spain, France, and Italy, with 25–70% of adult cases being
related to HIV infection and up to 9% of AIDS cases developing VL
[7,8]. In addition to the classical vector-based disease transmission,
an anthroponotic cycle has emerged among intravenous drug users
where syringes replace the sand fly vector [9–14]. Recently, L.
infantum parasites have been found to have spread northward in
continental Italy perhaps due to climatic changes [15–17]. Dogs are
the main reservoir hosts for L. infantum, being part of the domestic
(pet dogs) and peridomestic (stray dogs and wild canids) transmission
cycles. The prevalence of canine leishmaniasis is high in all
European Mediterranean countries [18–20].
The gold standard method for typing Leishmania is still
Multilocus Enzyme Electrophoresis (MLEE, isoenzyme analysis).
Most widely used is the Montpellier system (MON) which is based
on the analysis of 15 enzymes [21]. Leishmania infantum is
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characterized by a broad enzymatic polymorphism. At present this
species includes 31 zymodemes of which 30 have been found in
humans [22]. Some of them were related to VL only (e.g. MON-
27, 28, 72, 77, 187), others only to cutaneous leishmaniasis (CL)
(e.g. MON-11, 29, 33, 78, 111), and few were isolated from both
VL and CL cases (e.g. MON-1, 24, 34, 80). In L. infantum/HIV co-
infections the tropism of some zymodemes (MON-24, 29, 33, 78)
has changed from CL to VL [23–25].
MON-1 is the most prevalent zymodeme; it occurs in more than
30 countries worldwide, and represents approximately 70% of all
identified strains [26]. In Europe, it varies between 88% in Southern
France [25], over 50% in Italy [27], 96.7% in Portugal [28] and 44–
58% in Spain [9,29,30]. Up to 73% of HIV/VL co-infections in
Europe are due to this zymodeme [24]. In immunocompetent
patients MON-1 causes up to 90% of VL cases, but only 20% of CL
cases [11]. MON-1 is also the prevalent zymodeme in dogs
[19,25,29] whilst other zymodemes such as MON-98, 108, 253, 77,
and 24 are found occasionally. In contrast, MON-1 has only been
detected in 18% of the sand fly samples [29].
Epidemiological studies on VL caused by L. infantum require the
use of techniques that are able to differentiate MON-1 strains. The
first indications for heterogeneity among MON-1 strains were
based on RAPD analyses [31–34], analysis of three microsatellite
markers [35], PCR-RFLP of the intergenic cpb and intragenic gp63
regions [36] and RFLP analysis of minicircle kDNA [37,38].
Microsatellites are tandemly repeated stretches of short
nucleotide motives of 1–6 bp ubiquitously distributed in eukaryotic
genomes. They mutate at rates five to six orders of magnitude
higher than the bulk of DNA. These highly polymorphic and co-
dominant markers have been shown to be very useful for
population studies [39] and have been applied for a number of
species, among them quite recently L. tropica [40] and the L.
donovani complex [41]. A comparison of different genotyping
methods targeting Leishmania DNA regions with different molec-
ular clocks [42] revealed that kDNA PCR-RFLP and multilocus
microsatellite typing (MLMT) were the most powerful tools for
MON-1 strain tracking.
In the present study we performed MLMT using a set of 14
microsatellite markers for 141 strains of L. infantum of different
zymodemes with strong sampling emphasis on MON-1, mainly
from Spain, Portugal and Greece in order to investigate the
population structure and dynamics in the corresponding natural
foci. We also attempted to correlate microsatellite patterns with
host specificity and manifestation of the disease. Strains from
recurrent infections were included to test whether MLMT was
able to differentiate between relapse and re-infection.
Materials and Methods
Parasite cultures and DNA extraction
Sources, designation, geographical origins, MLEE identification
and clinical manifestation of the Leishmania infantum strains are
listed in Table 1. The 66 Spanish strains were collected from
humans and dogs in four regions-Madrid, Ibiza, Majorca, and
Catalonia. Forty four strains, from humans, dogs and sand fly
vectors, were obtained from four Portuguese regions: Metropolitan
region of Lisbon, Alentejo, Algarve, Alto Douro. The 16 human
and canine strains from Greece are originating from two foci-
Athens and Crete. The seven strains from France were collected in
four of the five known endemic foci: Ce´vennes, Coˆte d’Azur,
Provence, and Pyre´ne´es-Orientales. Additional strains or the
respective DNA samples were obtained from the following culture
collections: Centre National de Re´fe´rence des Leishmania, Mon-
tpellier, France; KIT (Royal Tropical Institute), Amsterdam,
Netherlands; WHO’s Jerusalem Reference Centre for Leishman-
iases, Hebrew University–Hadassah Medical School, Jerusalem,
Israel; London School of Hygiene and Tropical Medicine,
London, UK. The strain set included isolates from 12 relapse
cases. Ten of them represented two episodes of infection (original
infection and relapse), one three and another one four episodes.
All parasites were cultivated as described previously [37,43,44].
DNA was isolated using proteinase K-phenol/chloroform extrac-
tion [45], suspended in TE-buffer or distilled water and stored at
4uC until use.
PCR amplification assays and electrophoretic analysis of
the microsatellite markers
A set of fourteen primer pairs were used for microsatellite
amplification (Table 2) as previously described [41,46]. Frag-
ments containing single microsatellites were analyzed by either
MetaPhor agarose gel electrophoresis, PAGE or capillary
electrophoresis. Four percent MetaPhor agarose gels (BioWhit-
taker Molecular Applications, USA) were used basically for a pre-
screening of the strains for polymorphisms [46]. For PAGE 6 to
15 ml of the PCR product were mixed with loading buffer and run
under non-denaturating conditions on 12% polyacrylamide gels at
1 kV for 6 h. Gels were silver stained and dried [47]. For high
throughput studies PCR products from amplified microsatellites
were analyzed with the fragment analysis tool of the CEQ 8000
automated genetic analysis system of Beckman Coulter, USA [46],
using fluorescence-conjugated forward primers (Proligo, France)
for microsatellite amplification.
Data analysis
Population structure was investigated by the STRUCTURE
software [48], which applies a Bayesian model-based clustering
approach. This algorithm identifies genetically distinct populations
on the basis of allele frequencies. Genetic clusters are constructed
from the genotypes identified, estimating for each strain the
fraction of its genotype that belongs to each cluster. This clustering
method proved superior to distance-based approaches for
processing data sets of low variability like those presented by L.
infantum MON-1. The following parameters were used: burning
Author Summary
Visceral leishmaniasis is caused by protozoan parasites of
the genus Leishmania. This disease is a public health
problem in countries bordering the Mediterranean, in
China, and South America. Until now, isoenzyme analysis, a
method with several advantages but also some limitations,
is the gold standard for typing the causative agent L.
infantum. We have developed a new method based on
hypervariable DNA markers, the microsatellites. Its higher
discriminatory power, genotype-based analysis, the possi-
bility to use biological material instead of parasite cultures,
and the fast analysis are the major improvements. We
could demonstrate for the first time that there exist
different geographically determined populations within
the predominant zymodeme of L. infantum, which has
important epidemiological implications. We also tested for
relationships between genotype and clinical picture and/
or host background. Leishmania is considered to repro-
duce mainly clonally; however, we found some indication
for recombination in our study. Our work constitutes a
solid basis for further population and epidemiological
studies of L. infantum by completing the existing
microsatellite database by analysing strains from other
endemic foci.
MLMT of Leishmania infantum
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Table 1. Designation and characteristics of Leishmania infantum strains used in this study
Country (number
of strains)
Region (number of MON-1
strains of each region) MON Pathologya Lab code WHO-Code
Population
assignment K=4
Spain Majorca (12) 1 VL/HIV+ INF-41 MHOM/ES/1993/PM1 2
(66) Majorca 1 VL/HIV+ ES11(I) MHOM/ES/2001/LLM-981 2
Majorca 1 2. Episode of ES11(I) ES12(I) MHOM/ES/2002/LLM-1122 2
Majorca 1 VL/HIV+ ES13(I) MHOM/ES/2001/LLM-1048 3
Majorca 1 VL/HIV+ ES14(I) MHOM/ES/2001/LLM-1049 3
Majorca 1 CL/HIV+ ES15(I) MHOM/ES/2002/LLM-1150 2
Majorca 1 VL ES16(I) MHOM/ES/2002/LLM-1109 3
Majorca 1 CanL ES17(I) MCAN/ES/2001/LLM-1008 2
Majorca 1 CanL ES18(I) MCAN/ES/2001/LLM-1007 2
Majorca 1 CanL ES19(I) MCAN/ES/2001/LLM-1038 2
Majorca 1 3. Episode of ES11(I) ES13(III) MHOM/ES/2001/LLM-1035 2
Majorca 1 4. Episode of ES11(I) ES14(III) MHOM/ES/2002/LLM-1167 2
Ibiza (15) 1 CanL ES20(I) MCAN/ES/2002/LLM-1149 2
Ibiza 1 CanL ES21(I) MCAN/ES/2002/LLM-1155 2
Ibiza 1 CanL ES22(I) MCAN/ES/2002/LLM-1203 2
Ibiza 1 CanL ES23(I) MCAN/ES/2002/LLM-1139 2
Ibiza 1 CanL ES24(I) MCAN/ES/2002/LLM-1141 2
Ibiza 1 CanL ES25(I) MCAN/ES/2002/LLM-1158 2
Ibiza 1 CanL ES10(II) MCAN/ES/2003/LLM-1228 2
Ibiza 1 CanL ES11(II) MCAN/ES/2003/LLM-1233 2
Ibiza 1 CanL ES12(II) MCAN/ES/2003/LLM-1238 2
Ibiza 1 CanL ES13(II) MCAN/ES/2003/LLM-1240 2
Ibiza 1 CanL ES14(II) MCAN/ES/2001/LLM-1215 2
Ibiza 1 CanL ES15(II) MCAN/ES/2003/LLM-1237 2
Ibiza 1 CanL ES16(II) MCAN/ES/2003/LLM-1241 2
Ibiza 1 CanL ES17(II) MCAN/ES/2003/LLM-1226 2
Ibiza 1 CanL ES18(II) MCAN/ES/2003/LLM-1267 2
Madrid (20) 1 VL/transplant. ES1(I) MHOM/ES/2001/LLM-984 4
Madrid 1 VL/HIV+ ES2(I) MHOM/ES/2001/LLM-983 3
Madrid 1 VL ES3(I) MHOM/ES/2001/LLM-980 4
Madrid 1 VL/HIV+ ES4(I) MHOM/ES/2002/LLM-1181 3
Madrid 1 2. Episode of ES4(I) ES5(I) MHOM/ES/2002/LLM-1212 3
Madrid 1 VL/HIV+ ES6(I) MHOM/ES/2002/LLM-1166 4
Madrid 1 CanL ES7(I) MCAN/ES/2001/LLM-1006 3
Madrid 1 CanL ES8(I) MCAN/ES/2001/LLM-1014 3
Madrid 1 CanL ES9(I) MCAN/ES/2001/LLM-1037 2
Madrid 1 CanL ES10(I) MCAN/ES/2001/LLM-1040 3
Madrid 1 VL/HIV+ ES1(III) MHOM/ES/2002/LLM-1220 2
Madrid 1 2. Episode of ES1(III) ES2(III) MHOM/ES/2002/LLM-1217 2
Madrid 1 CanL ES1(II) MCAN/ES/2001/LLM-1068 3
Madrid 1 CanL ES2(II) MCAN/ES/2001/LLM-1102 1
Madrid 1 CanL ES3(II) MCAN/ES/2001/LLM-1106 3
Madrid 1 CanL ES5(II) MCAN/ES/2002/LLM-1113 3
Madrid 1 CanL ES6(II) MCAN/ES/2001/LLM-1116 3
Madrid 1 CanL ES7(II) MCAN/ES/2001/LLM-1128 3
Madrid 1 CanL ES8(II) MCAN/ES/2001/LLM-1136 3
Madrid 1 CanL ES9(II) MCAN/ES/2001/LLM-1148 2
Catalonia (3) 1 CL INF-43 MHOM/ES/1986/BCN16 3
Catalonia 1 VL ES7(III) MHOM/ES/2002/LLM-1184 3
MLMT of Leishmania infantum
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Country (number
of strains)
Region (number of MON-1
strains of each region) MON Pathologya Lab code WHO-Code
Population
assignment K=4
Catalonia 1 2. Episode of ES7(III) ES8(III) MHOM/ES/2003/LLM-1232 3
Madrid 198 VL/HIV+ INF-37 MHOM/ES/88/LLM175 4
Madrid 199 VL/HIV+ INF-55 MHOM/ES/92/LLM373 4
Catalonia 77 CanL INF-32 MCAN/ES/86/LEM935 3/4
Valencia 183 VL/HIV+ INF-46 MHOM/ES/91/LEM2298 4
Madrid 24 VL/HIV+ ES5(III) MHOM/ES/97/LLM-707 4
Madrid 24 2. Episode of ES5(III) ES6(III) MHOM/ES/97/LLM-709 4
Majorca 24 VL/HIV+ ES9(III) MHOM/ES/98/LLM-810 2/4
Majorca 24 2. Episode of ES9(III) ES10(III) MHOM/ES/99/LLM-846 2/4
unknown 24 CL INF-04 MHOM/ES/87/Lombardi 4
Madrid 27 VL/HIV+ ES3(III) MHOM/ES/2001/LLM-1036 4
Madrid 27 2. Episode of ES3(III) ES4(III) MHOM/ES/2003/LLM-1254 4
Andalucia 34 VL/HIV+ ES11(III) MHOM/ES/98/LLM-745 4
Andalucia 34 2. Episode of ES11(III) ES12(III) MHOM/ES/99/LLM-879 4
Madrid 34 VL/HIV+ ES15(III) MHOM/ES/95/LLM-531 4
Madrid 34 2. Episode of ES15(III) ES16(III) MHOM/ES/98/LLM-780 4
Madrid 34 3. Episode of ES15(III) ES17(III) MHOM/ES/2001/LLM-1034 4
Portugal Alto Douro (10) 1 CanL PT5(I) MCAN/PT/1989/IMT162 3
(44) Alto Douro 1 Phlebotomus PT6(I) IARI/PT/1989/IMT169 2
Alto Douro 1 Phlebotomus PT7(I) IARI/PT/1989/IMT170 2
Alto Douro 1 VL PT8(I) MHOM/PT/2002/IMT279 3
Alto Douro 1 VL PT9(I) MHOM/PT/2002/IMT288 3
Alto Douro 1 CL PT10(I) MHOM/PT/2003/IMT337 3
Alto Douro 1 VL PT7(II) MHOM/PT/2004/IMT359 3
Alto Douro 1 VL PT8(II) MHOM/PT/2004/IMT360 3
Alto Douro 1 CanL PT13(II) MCAN/PT/1989/IMT160 2
Alto Douro 1 CanL PT14(II) MCAN/PT/1989/IMT161 3
Algarve (3) 1 CanL PT1(I) MCAN/PT/1993/IMT193 3
Algarve 1 Phlebotomus PT2(I) IPERN/PT/1993/IMT189 3/4
Algarve 1 CanL PT17(II) MCAN/PT/1994/IMT204 3
Alentejo (4 MON-1) 1 CanL PT3(I) MCAN/PT/1995/IMT205 3
Alentejo 1 CanL PT4(I) MCAN/PT/2003/IMT328 3
Alentejo n.d. VL PT9(II) MHOM/PT/2004/IMT363 4
Alentejo 1 CanL PT15(II) MCAN/PT/2004/IMT355 3
Alentejo 1 CanL PT16(II) MCAN/PT/2004/IMT356 3
Lisbon-MRL (25)b 1 CL INF-44 MHOM/PT/2000/IMT260 3
Lisbon-MRL 1 CanL PT11(I) MCAN/PT/1997/IMT229 3
Lisbon-MRL 1 CanL PT12(I) MCAN/PT/2003/IMT300 3
Lisbon-MRL 1 CanL PT13(I) MCAN/PT/2003/IMT327 3
Lisbon-MRL 1 CanL PT14(I) MCAN/PT/2003/IMT316 3
Lisbon-MRL 1 CanL PT15(I) MCAN/PT/2003/IMT329 3
Lisbon-MRL 1 CanL PT16(I) MCAN/PT/2003/IMT330 3
Lisbon-MRL 1 CanL PT17(I) MCAN/PT/2003/IMT338 3
Lisbon-MRL 1 CanL PT18(I) MCAN/PT/2003/IMT339 3
Lisbon-MRL 1 VL/HIV+ PT19(I) MHOM/PT/1989/IMT163 3
Lisbon-MRL 1 VL/HIV+ PT20(I) MHOM/PT/2002/IMT293 3
Lisbon-MRL 1 2. Episode of PT20(I) PT21(I) MHOM/PT/2003/IMT293-B 3
Lisbon-MRL 1 VCL/HIV+ PT22(I) MHOM/PT/2002/IMT294 3
Table 1. Cont.
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Country (number
of strains)
Region (number of MON-1
strains of each region) MON Pathologya Lab code WHO-Code
Population
assignment K=4
Lisbon-MRL 1 VL/HIV+ PT23(I) MHOM/PT/2002/IMT296 3
Lisbon-MRL 1 VL/HIV+ PT24(I) MHOM/PT/2003/IMT299 3
Lisbon-MRL 1 VL/HIV+ PT1(II) MHOM/PT/2000/IMT262 3
Lisbon-MRL 1 2. Episode of PT1(II) PT2(II) MHOM/PT/2000/IMT262-A 3
Lisbon-MRL 1 VL/HIV+ PT3(II) MHOM/PT/1993/IMT184 3
Lisbon-MRL 1 VL PT4(II) MHOM/PT/1988/IMT151 3
Lisbon-MRL 1 VCL/HIV+ PT5(II) MHOM/PT/2004/IMT362 3
Lisbon-MRL 1 VL/HIV+ PT6(II) MHOM/PT/2004/IMT364 3
Lisbon-MRL 1 CanL PT10(II) MCAN/PT/2003/IMT329 3
Lisbon-MRL 1 CanL PT11(II) MCAN/PT/2003/IMT331 3
Lisbon-MRL 1 CanL PT12(II) MCAN/PT/2003/IMT354 3
Lisbon-MRL 1 fox PT18(II) VUL/PT/1982/IMT108 3
Lisbon-MRL 80 VL/HIV+ PT25(I) MHOM/PT/98/IMT238 4
France Ce´vennes (2) 1 VL INF-39 MHOM/FR/78/LEM75 3
(7) Ce´vennes 1 CL INF-42 MHOM/FR/97/LSL29 3
Coˆte d’Azur (1) 1 VL INF-40 MHOM/FR/95/LPN114 1
Provence 108 CanL INF-35 MCAN/FR/87/RM1 2
Pyre´ne´es-Orientales 29 CL INF-45 MHOM/FR/96/LEM3249 4
Pyre´ne´es-Orientales 11 CL INF-47 MHOM/FR/80/LEM189 4
unknown n.d. VL INF-03 MHOM/FR/62/LRC-L47 4
Italy unknown 228 VL/HIV+ INF-56 MHOM/IT/94/ISS1036 4
(2) Sicily 188 VL/HIV+ INF-57 MHOM/IT/93/ISS800 4
Malta Malta 78 CL INF-48 MHOM/MT/85/BUCK 4
(1)
Greece Crete (4) 1 VL GR3 MHOM/GR/2001/GH3 1
(16) Crete 1 VL GR4 MHOM/GR/2001/GH5 1
Crete 1 CanL GR14 MCAN/GR/2001/GD7 1
Crete 1 VL GR16 MHOM/GR/2002/GH12 1
Crete 98 CanL GR13 MCAN/GR/2003/GD5 1
Crete 98 CanL GR11 MCAN/GR/2001/GD3 1
Crete 98 CanL GR12 MCAN/GR/2001/GD4 1
Crete 98 CanL GR15 MCAN/GR/2001/GD8 1
Athens (7) 1 VL GR1 MHOM/GR/2001/GH1 1
Athens 1 VL GR2 MHOM/GR/2001/GH2 1
Athens 1 VL 2. Episode of GR5 GR7 MHOM/GR/2001/GH8 1
Athens 1 VL GR8 MHOM/GR/2001/GH9 1
Athens 1 VCL/HIV+ GR9 MHOM/GR/2001/GH10 1
Athens 1 VL GR10 MHOM/GR/2001/GH11 1
Athens 1 VL GR17 MHOM/GR/1978/L4 3
Athens 98 VL GR5 MHOM/GR/2001/GH6 1
Turkey unknown n.d. CanL INF-10 MCAN/TR/96/EP16 1
(2) unknown n.d. unknown INF-11 MHOM/TR/94/EP3 1
Israel unknown n.d. CanL INF-12 MCAN/IL/94/LRC-L639 1
(2) unknown n.d. CanL INF-13 MCAN/IL/96/LRC-L685 1
Tunisia unknown 1 VL INF-01R MHOM/TN/80/IPT1R 1
(1)
aVL-Visceral leishmaniasis, CL-Cutaneous leishmaniasis, VCL-Viscero-cutaneous leishmaniasis, CanL-Canine leishmaniasis;
bMetropolitan Region of Lisbon;
RWHO-reference strain; n.d. not defined.
doi:10.1371/journal.pntd.0000261.t001
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period of 20,000 iterations, probability estimates based on 200,000
Markov Chain Monte Carlo iterations. The most appropriate
number of populations was determined by comparing log-
likelihoods for values of K between 1 and 16. The log-likelihood
values were compared in a diagram. At the plateau (maximum) of
the derived Gaussian graph the value of K captures the major
structure of the populations. In addition we calculated DK, which
is based on the rate of change in the log probability of data
between successive K values [49]. Ancestral source populations
were identified by decreasing the number of K.
Phylogenetic analysis was based on microsatellite genetic
distances, calculated with the program MICROSAT [50] for the
numbers of repeats within each locus using two different measures:
DAS (Dps), based on the proportion of shared alleles [51] and
Chord-distance [52]. Both distances follow the infinite allele model
(IAM). Neighbor-joining trees (NJ) of both distance matrices were
constructed in PAUP, version 4.0b8 [53]. Confidence intervals
were calculated by bootstrapping (100 replications) [54] using the
program POPULATIONS 1.2.28 (http://www.legs.cnrs-gif.fr/
bioinfo/populations).
For visualising the genetic substructure at population and
individual level we applied a factorial correspondence analysis
(FCA) implemented in the GENETIX software [55]. This test
places the individuals according to the similarity of their allelic
state in a three dimensional space. Microsatellite markers as well as
populations were analyzed with respect to diversity of alleles (A),
expected (gene diversity) and observed heterozygosity (He and Ho,
respectively), and the inbreeding coefficient FIS applying GDA
(http://hydrodictyon.eeb.uconn.edu/people/plewis/software.php)
and GENEPOP 3.4 [56].
Genetic differentiation and gene flow [57] was assessed by F-
statistics calculating the FST (theta) values (IAM) [58] with the corres-
ponding p-values (confidence test) using the MSA software [59]. Mig-
ration rates (gene flow) Nm were calculated as Nm= 0.25 (1-FST)/FST
[60]. Indices of association (IA) were calculated to test each population
for clonality and recombination using MULTILOCUS [61].
Table 2. Characteristics of the 14 microsatellite markers used for population analysis of Mediterranean Leishmania infantum
Nr. Marker Population n Repeat array
Fragment size
array [bp] A He Ho FIS
1 Lm2TG MON-1 113 TG12–27 116–146 9 0.758 0.071 0.906
non-MON-1 26 TG 12–29 116–150 11 0.848 0.154 0.821
2 TubCA MON-1 113 CA9–13 80–88 2 0.018 0 1.000
non-MON-1 26 CA 9–16 80–94 5 0.523 0.038 0.928
3 Lm4TA MON-1 113 TA 4–16 63–87 9 0.768 0.036 0.954
non-MON-1 26 TA 9–14 73–83 4 0.533 0.038 0.929
4 Li 41–56 MON-1 113 CA 9–12 88–94 3 0.155 0.009 0.943
non-MON-1 26 CA 9–13 88–96 4 0.338 0.077 0.776
5 Li 46–67 MON-1 113 CA 6–9 74–80 2 0.018 0.018 20.004
non-MON-1 26 CA 6–9 74–80 4 0.709 0.231 0.679
6 Li 22–35 MON-1 113 CA 10–25 88–118 10 0.690 0.080 0.885
non-MON-1 26 CA 6–28 80–124 13 0.876 0.192 0.784
7 Li 23–41 MON-1 113 GT 7–17 67–87 5 0.294 0.027 0.910
non-MON-1 26 GT 15–23 83–99 8 0.786 0.269 0.662
8 Li 45–24 MON-1 113 CA 13–22 101–119 6 0.505 0.044 0.913
non-MON-1 26 CA 7–20 89–115 6 0.643 0.077 0.882
9 Li 71–33 MON-1 113 TG 11–12 105–107 2 0.052 0 1.000
non-MON-1 26 TG 11–27 105–137 7 0.534 0.231 0.573
10 Li 71-5/2 MON-1 99 CA 8–16 108–124 4 0.302 0.020 0.933
non-MON-1 26 CA 7–9 106–110 3 0.274 0 1.000
11 Li 71-7 MON-1 113 CA 12–14 98–102 3 0.148 0.035 0.761
non-MON-1 26 CA 8–13 90–100 5 0.518 0.038 0.927
12 CS20 MON-1 113 TG 17–19 81–85 3 0.331 0 1.000
non-MON-1 26 TG 18–22 83–91 5 0.750 0.154 0.798
13 LIST7031 MON-1 113 CA 10–12 109–113 3 0.353 0.045 0.874
non-MON-1 26 CA 10–12 109–113 3 0.528 0.077 0.857
14 LIST7039 MON-1 113 CA 14–17 205–211 3 0.165 0.018 0.892
non-MON-1 26 CA 15–20 207–217 6 0.729 0.077 0.896
overall MON-1 112 4.6 0.325 0.029 0.912
non-MON-1 26 5.6 0.614 0.118 0.810
A, number of alleles; n, sample size; Ho, observed heterozygosity; He, expected heterozygosity; FIS, inbreeding coefficient. Two of the four heterozygous strains with
mixed MON-1/non-MON-1 alleles (PT2(I) and INF-32) have been removed from the data set, in case of ES9(III) and ES10(III) only the non-MON-1 genotype has been
considered, as these strains have been identified as MON-24 by MLEE.
doi:10.1371/journal.pntd.0000261.t002
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Ethical considerations
Strains collected in Greece. The strains were isolated from
the human patients’ blood during the process of laboratory diagnosis
of the disease at the University Hospital in Heraklion, Crete. The
patients were aware that their blood samples were needed for
diagnosis of the disease using serology and/or molecular diagnostic
methods, isolation of the parasite being the gold standard. Doctors
obtained the written consent of the patients. Both the study and the
protocols used were approved by the Ethical Scientific Committee of
the Medical School of the University of Crete.
Strains collected in Portugal. The Portuguese strains are
from the IHMT cryobank and were obtained by the diagnosis
service that the Leishmaniosis Unit has with the hospitals. All
studies involving these strains were approved be the ethical
committee of the IHMT. They were included in a previous
publication [28], which included the ethical approval. The present
study was approved by the Ethics Committee of the Instituto de
Higiene e Medicina Tropical, Universidade Nova de Lisboa.
Strains collected in Spain. Most of the strains from human
were isolated from patients included in two different clinical trials,
both previously approved by the corresponding Ethical
Committees of the Hospitals taking part in the trials (Hospital
Son Dureta (Palma de Mallorca), Fundacio´n Jime´nez Dı´az
(Madrid), Hospital Universitario Vall d’Hebro´n (Barcelona) and
Hospital Universitario Virgen del Rocı´o (Sevilla)). All strains
isolated from biological samples were received by the laboratory
(the Reference Laboratory for Leishmaniasis for the hospitals of
the National Health System) in order to carry out a diagnostic
identification requested by the physicians. For this diagnostic
activity an informed consent and ethical clearance is not needed in
Spain. In the case of canine leishmaniasis, the biological samples
were also obtained with diagnostic purposes.
Strains received from the strain collection in Montpellier,
France. In the sampling of strains referring to this paper, the
human strains from Montpellier are old strains isolated between
1962 and 1996, at least more than 10 years ago, which have
already been object of many publications. Some of those strains
are reference strains of zymodemes, as in the case of the L. infantum
WHO reference strain IPT1. The human strains received in the
Montpellier laboratory from other French laboratories, are
received for identification purpose, within a diagnostic approach
of a physician. This is why the required consent of the patient is a
tacit agreement, as usual for biological diagnosis, and not a written
consent (written consent in France is required only for a few
diagnostics). The identification is carried out for medical purpose
and lead consequently to isolation of the parasite. This parasite
(the strain) is a foreign element obtained from the patient’s body,
on which the patient has no rights. The rights attached to human
body do not include foreign elements extracted from it. This is the
reason for what there is no need of patient consent for using the
strains. These arguments were provided in 2005 by the juristic
department of INSERM (France).
Strains received from the strain collection in London
(LSTMH), UK. Similarly as in the case of the strains from
France the human strains from London are old strains isolated
many years ago, and stored in the cryobank. They also have
already been object of many publications.
Results
Population structure of European L. infantum: genetic
diversity, differentiation and gene flow
A total of 106 different MLMT genotypes based on 14
microsatellite markers were identified for 141 strains of L. infantum
mostly from Southern Europe. A Bayesian model-based clustering
algorithm implemented in the software STRUCTURE was used
to infer the population structure of European L. infantum based on
these MLMT data. According to DK, the most probable number
of populations for the complete data set of 141 strains was four: (1)
MON-1 from Greece, Turkey, Israel, and Tunisia (+1 strain from
France); (2) MON-1 from Majorca and Ibiza (Spain); (3) MON-1
from Portugal and mainland Spain; and (4) non-MON-1 strains
from Spain, Portugal, Italy, Malta (Figure 1). Ancestral source
populations were identified by successively increasing the number
of populations (K) from 2 as indicated by the bars next to the tree
in Figure 2. The first and most important split at K= 2 divided
non-MON-1 from MON-1 strains. The MON-1 cluster was
subdivided at K= 3 into a group of Iberian strains, which included
strains from France, and a group comprising strains from Greece,
Turkey, Israel, and Tunisia. Finally, at K = 4, the Iberian group
split into mainland and Balearic Islands (Table 1).
One hundred and fifteen strains representing 84 distinct
genotypes formed the MON-1 group and 26 strains representing
22 genotypes the non-MON-1 group, respectively. The assign-
ment of strains to these groups was not always compatible with
zymodeme identification: three Spanish MON-1 strains ES1(I),
ES3(I), ES6(I), clustered with non-MON-1 strains, whereas strains
INF-32 (MON-77), INF-35 (MON-108) and all Greek MON-98
strains grouped with the MON-1 strains. Populations as defined by
STRUCTURE were used for all subsequent population genetics
analyses.
In addition to the model-based algorithm, we used a genetic
distance-based approach to infer the population structure of
European L. infantum (Figure 2). The same 4 major populations as
defined by STRUCTURE were detected, as indicated by bars,
however they were not supported by significant bootstrap values
(data not shown). This may be due to the extremely high similarity
of these strains, a certain amount of homoplasy and the existence
of strains with mixed or intermediate genotypes. Bootstrap values
.50% were obtained only for nodes between some subgroups
inside the major clusters. The identical results obtained by two
different methods, however, strongly support the existence of these
particular main populations. The MON-1 and non-MON-1
clusters were monophyletic. Zymodemes MON-77, 108 and 98
were, again, members of the MON-1 cluster. There were two
subclusters of non-MON-1 strains that were also observed in
STRUCTURE at K= 5 (data not shown): one comprises
predominantly MON-34, MON-27 and MON-80, the other
MON-11, 29, 183, 188, 198, 199, 228. MON-24 is present in both
subclusters. Long branches in the non-MON-1 group indicated a
higher diversity among these strains.
The number of microsatellite alleles ranged from 2–10 (mean
4.6) for the MON-1 strains, and from 3–13 (mean 5.6) for the non-
MON-1 strains (Table 2). The most variable markers were Li 22–
35 and Lm2TG, the least variable ones Li 46–67 and TubCA.
The observed heterozygosity (Ho) varied between 0–0.08 for
MON-1 strains, and 0–0.269 for non-MON-1 strains, indicating
that most microsatellite loci were heterozygous in at least one
strain, with a higher degree of heterozygosity in non-MON-1
strains. The expected heterozygosity (He) as a measure of genetic
diversity was between 0.018–0.768 (MON-1) and 0.274–0.876
(non-MON-1), and, in most of the markers, much higher than the
mean Ho (0.029 MON-1 and 0.118 non-MON-1). The mean of
the inbreeding coefficients was 0.912 and 0.81 for MON-1 and
non-MON-1 strains, respectively, pointing to a homozygotes
predominance. The non-MON-1 strains were more diverse, with
greater distances on the Neighbor-joining tree, higher numbers of
allelic variants and higher values of diversity measures, in spite of
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the much smaller number of strains, perhaps reflecting the
combination of distinct zymodemes in this group.
Traces of gene flow were detected between the four populations
using the Bayesian algorythm (Figure 1A, 3). Several strains
could not be assigned to only one population by STRUCTURE as
they showed mixed ancestry. Some strains were considered more
likely to belong to one of the populations, but others had clear
shared memberships for two populations (e.g. ES9(III), ES10(III),
PT2(I), and INF-32) (Figure 3; Table 3, 4). ES9(III) and
ES10(III) (human isolate with its relapse) had heterozygous
combinations of alleles characteristic for non-MON-1 strains and
MON-1 strains (population 2) for 10 of the 14 markers. The sand
fly isolate PT2(I) had such MON-1 (population 3)/non-MON-1
allele combinations in 9 markers. The remaining 5 homozygous
markers were in general not discriminating between MON-1 and
non-MON-1 strains. INF-32 presented also a mixture of patterns
typical for non-MON-1 and MON-1 (population 3), being
heterozygous in 7 markers. In addition there were several strains
which also have alleles typical for both, the MON-1 and non-
MON-1 group, however with MON-1 alleles clearly predominat-
ing, as the canine strain PT13(II), the sandfly strains PT7(I) and
the human strains PT8(I) and PT8(II) (Tables 3, 4). The two
sandfly isolates PT7(I) and PT6(I) as well as PT8(I) and PT8(II)
from Alto Douro showed an unique allele for marker Li 22–35
(118 bp) that differed significantly from the usual MON-1 alleles
and rather resembled the range of non-MON-1 alleles (Tables 4,
5). ES16(I) is homozygous for all loci, however represents a
combination of alleles typical for different populations, with
dominating population 3 membership (Figure 3, Table 3). All
those strains (PT13(II), PT8(I), PT8(II), PT7(I), ES16(I)) seem to
exhibit mosaic genotypes. Three of the strains showing heterozy-
gous MON-1 and non-MON-1 alleles (PT2(I), ES9(III), ES10(III))
had in the NJ tree an intermediate position between the two
respective clusters. Strain INF-32, although being heterozygous for
some microsatellite markers was here part of the MON-1 cluster,
suggesting the predominance of MON-1 traits.
The four populations recognized by model-based and distance-
based analyses were also supported by F statistics. All FST values
(Table 6) were .0.25 and significant (p = 0.0001) indicating
strong genetic differentiation between the four populations.
Populations 2 (Spain Majorca and Ibiza) and 3 (Portugal and
Spain mainland) were the most closely related samples, an
observation that is highly congruent with their geographic
distribution and the maritime transport. Moreover, migration
rates (Nm) estimates between all four L. infantum populations were
low (Table 6). The graphical representation of factorial
Figure 1. Population structure of Mediterranean L. infantum as inferred by STRUCTURE on the basis of data for 14 microsatellite
markers obtained for 141 strains. (A) Barplot for K= 4-each of the strains is represented by a single vertical line divided into K colors, where K is
the number of populations assumed. Each color represents one population, and the length of the colors segment shows the strain’s estimated
proportion of membership in that population. (B) Distribution of Mediterranean L. infantum MON-1 strains belonging to populations 1–3 in the
respective endemic foci. Pie-charts show the proportion of each population sampled in the respective geographical region. Colors correspond to the
population specific ones in Figure 1A.
doi:10.1371/journal.pntd.0000261.g001
MLMT of Leishmania infantum
www.plosntds.org 8 July 2008 | Volume 2 | Issue 7 | e261
correspondence analysis (FCA) of the MLMT data (Figure 4)
clearly mirrors the population structure parameters. The split
between MON-1 and non-MON-1 strains (K = 2) and the higher
genotypic diversity within non-MON-1 strains is apparent from
Figure 4A. The three main MON-1 populations are clearly
separated, when only MON-1 strains were analyzed (Figure 4B).
Characterization of populations: genetic diversity and
differentiation, population-specific alleles
The mean number of alleles (MNA) ranged from 2.79–3.07
among the three MON-1 populations, and was 6.29 for the non-
MON-1 population (Table 7). The proportion of polymorphic
loci was 0.786 for all three MON-1 populations and 1.0 for the
Figure 2. Neighbor-joining tree inferred from Dps-distances calculated for the data of 14 microsatellite markers and all 141 L.
infantum strains. Geographical origins, zymodemes and clinical manifestation are shown. Phlebotomus strains are marked by grey rectangles,
relapses by white rectangles. Four strains with mixed MON-1/non-MON-1 ancestry are marked by an asterix. Populations as inferred by STRUCTURE
K= 2, K= 3 and K= 4 are indicated by bars in different colors next to the tree. Midpoint rooting was applied for the NJ tree, no outgroup has been
used.
doi:10.1371/journal.pntd.0000261.g002
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non-MON-1 population. The values of He differed between
MON-1 (0.197–0.348) and non-MON-1 (0.621). The highest
degree of heterozygosity was observed for the non-MON-1
population, the lowest in population 3 (MON-1 Portugal+Spain
Table 3. Population membership coefficients of strains of
combined MON-1/non-MON-1 genotypes or other mixed
ancestries
Population
1a Population 2a Population 3a
Population
4a
Greece Ibiza+Majorca PT+ES mainland non-MON1
INF-32 0.013 0.030 0.653 0.303
ES9(III) 0.082 0.288 0.037 0.593
ES10(III) 0.081 0.292 0.033 0.595
PT2(I) 0.021 0.006 0.478 0.495
ES16(I) 0.215 0.065 0.602 0.117
PT8(II) 0.011 0.244 0.558 0.187
PT8(I) 0.007 0.074 0.802 0.117
PT7(I) 0.077 0.809 0.025 0.089
PT13(II) 0.004 0.929 0.013 0.054
aPopulations 1–4 as inferred for K = 4 with STRUCTURE. PT-Portugal, ES-Spain.
doi:10.1371/journal.pntd.0000261.t003
Figure 3. Traces of gene flow between the L. infantum
populations shown by a triangle plot. The triangle plot of
proportion of ancestry from three sources designated population 1
(Greece), population 4 (non-MON-1) and combined populations 2 and 3
(Majorca/Ibiza and mainland Spain and Portugal) as inferred from K= 4
in STRUCTURE analysis shows traces of gene flow between the
populations. Each data point corresponds to a single strain whose
proportion of ancestry from each of the three sourcesis represented by
its proximity to the corresponding corner of the triangle. Strains of
mixed MON-1/non-MON-1 ancestry and mosaic genotypes are labeled
in grey (rectangles-most of the loci are heterozygous; ellipses-few loci
are heterozygous). ES16(I) is homozygous for all loci, however
representing a combination of alleles typical for different populations.
doi:10.1371/journal.pntd.0000261.g003
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mainland). There were no indications for aneuploidy in the tested
strains, since we never observed three or four peaks in the
electrophoregrams, suggestive of tetra- or triploidy of the tested
markers.
The inbreeding coefficient FIS ranged from 0.770 to 0.933
among the MON-1 populations and was lowest for the non-
MON-1 population (0.725). This suggests a high degree of
inbreeding in all four populations, but especially in the MON-1
populations 1 (Greece, Turkey, Israel, Tunisia) and 3 (Portugal+-
Spain mainland). Multilocus linkage associations were highly
significant for all four populations pointing to a predominantly
clonal reproduction within these populations.
Allele frequencies were different in the different populations and
group-specific alleles could be recognized (Table 5), which were
congruent with the population splits. The number of group specific
alleles was significantly higher among non-MON-1 strains (46)
than in the three MON-1 populations (4–7). Within MON-1,
population 1 (Greece, Turkey, Israel, Tunisia) had the highest
number of specific alleles and it appeared as most diverse
population, whereas population 3 was the least diverse.
Geographical differentiation within MON-1 populations
The distribution of the Mediterranean MON-1 strains
belonging to populations 1–3 in the respective countries and their
studied endemic foci as well as the proportion of each population
sampled in the respective geographical region are illustrated in
Figure 1B.
Population 1: Greece (Turkey, Israel, Tunisia). All but
one strain from Greece are members of population 1, which falls
into two main subclusters: one with most of the Greek strains
(Greek cluster) and the other with strains from Tunisia, Israel and
Turkey (East Mediterranean cluster). MLMT genotyping did not
discriminate between the regions of Athens and Crete, nor
between zymodemes MON-98 and MON-1. In fact, six strains
originating from Athens and from Crete, and also representing the
two zymodemes MON-1 and MON-98 had an identical genotype.
Among these identical strains there are human as well as canine
isolates.
Population 2: Spanish islands-Majorca and Ibiza. This
population includes all strains from Ibiza, nine of the twelve strains
from Majorca, four of the 17 strains from Madrid, one of the four
MON-1 (including MON-108) strains from France (Provence),
and unexpectedly three of the ten strains from Alto Douro,
Portugal. Eight of the 15 strains from Ibiza form one subcluster in
the NJ tree. The three strains from Alto Douro are closely related
to each other, and, as well as the strain from France, integrated in
the main population 2. There are two genotypes, identical for
three strains respectively, and three genotypes shared by two
strains each.
Population 3: mainland Spain and Portugal. This
population includes all but three strains from Portugal, 18 of the
47 strains from Spain, two of the four strains from France and a
single strain from Greece (GR17). All four endemic regions from
Portugal are represented in this population, without any
geographical correlation. Strains from Alto Douro were the most
diverse. Unique alleles were found in this region in comparison
with all other L. infantum strains for the 4 markers Lm2TG (126
bp), Li 23–41 (67 bp), Li 22–35 (118 bp) and Li 45–24 (119 bp)
(Table 4). In addition, four loci also had unique alleles in relation
to all other Portuguese strains: LIST7031 (109 bp), Lm4TA (75
bp), LIST7039 (211 bp) and Lm2TG (116, 126, 138 bp). They also
show the highest degree of heterozygosity among the Portuguese
strains. Nine strains from Portugal, but from different regions and
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host origins, had identical genotypes. Other strains, but in smaller
numbers, also had indistinguishable genotypes.
Correlation of MLMT genotypes with pathology and host
specificity
No correlation was found between MLMT genotypes and host
specificity or clinical manifestation (Figure 1A, 2). Human and
canine isolates were present in all MON-1 populations. Strains
from Leishmania/HIV+ co-infected patients were represented in all
four populations, whereas those few from CL cases were found
only in populations 3 (mainland Spain+Portugal) and 4 (non-
MON-1). The three strains isolated from Portuguese Phlebotomus
had quite peculiar genotypes. Strain PT2(I) from Algarve had
alleles characteristic for both, MON-1 and non-MON-1, as
described above. The two sand fly strains from Alto Douro, PT6(I)
and PT7(I), had a unique Li 22–35 allele (118 bp), found only in
strains from this endemic focus and differing significantly from the
Table 6. FST and migration rate values (Nm) values (upper and lower triangle, respectively) for the L. infantum populations
Populationa GR+TR+IL+TN ES Majorca+Ibiza PT+ES mainland non-MON-1
Greece+Turkey+Israel+Tunisia 0 0.431b 0.454 b 0.342 b
Spain Majorca+Ibiza 0.330 0 0.339 b 0.430 b
Portugal+Spain mainland 0.300 0.487 0 0.516 b
non-MON-1 0.481 0.331 0.234 0
aPopulations as assumed by STRUCTURE K = 4 for 139 strains of L. infantum from the Mediterranean region based on 14 microsatellite markers. Strains with mixed MON-
1/non-MON-1 genotype (INF-32 and PT2(I)) have been excluded. In the case of ES9(III) and ES10(III) only the non-MON-1 genotype has been considered, as these strains
have been identified as MON-24 by MLEE.
bp = 0.0001 for all FST values. ES-Spain, PT-Portugal, GR-Greece, TR-Turkey, IL-Israel, TN-Tunisia.
doi:10.1371/journal.pntd.0000261.t006
Figure 4. Factorial correspondence analysis (FCA) of L. infantum strains from the Mediterranean region. (A) All MON-1 and non-MON-1
strains included (141 strains). (B) Analysis of the three MON-1 populations (113 strains). TR–Turkey, TN–Tunisia, IL–Israel; Population 1 (Greece)–yellow
squares, population 2 (Majorca+Ibiza)–blue squares, population 3 (mainland Spain+Portugal)–white squares, population 4 (non-MON-1)–grey
squares.
doi:10.1371/journal.pntd.0000261.g004
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common MON-1 alleles (92 and 94 bp), which resembles rather
the range of non-MON-1 alleles. PT7(I) also presented both
MON-1 and non-MON-1 alleles for some of the markers, albeit
with MON-1 genotype dominating.
Of the 12 relapse cases, 6 occurred in MON-1, one in MON-1/
MON-98, two in MON-24, another two in MON-34 and one in
MON-27. Ten pairs of isolates presented identical MLMT
profiles. Identical genotypes were found for a case from Greece,
where the original strain was identified as MON-98 and the
relapse as MON-1 [62]. In the case with four episodes, strains
from episodes 1 and 2 (ES11(I)+ES12(I)) were identical but distinct
from strains from episodes 3 and 4 (ES13(III)+ES14(III)), which
were identical. The two pairs differed only in Lm2TG with an
additional allele present in episodes 1 and 2. The case with three
episodes (ES15, 16, 17(III)) had differences in two markers. The
first episode isolate showed two alleles for Li 23–41 and
LIST7031, the second only in Li 23–41 and the third was
homozygous for both markers.
Discussion
Population structure and sub-structure of European L.
infantum
The population structure of European L. infantum had, so far,
been poorly understood, because most strains belong to a single
zymodeme, MON-1. The recent development of microsatellite
Table 7. Characterization of the 4 populations found by STRUCTURE (K= 4) analysis of 139 strains of Mediterranean L. infantum
Populationa Country Region N P MNA He Ho FIS NAu IA
1 Greece (15/16) Athens (7/8) 22 0.786 2.86 0.348 0.0243 0.933 7 1.291
MON-1 Crete (8/8) (p,0.001)
Turkey (2/2) unknown
Israel (2/2) unknown
Tunisia (1/1) unknown
France (1/4) Coˆte d’Azur (1/1)
Spain (1/47)b Madrid (1/17) b
2 Spain (28/47) b Ibiza (15/15) 32 0.786 2.79 0.230 0.054 0.770 4 0.465
MON-1 Majorca (9/12) (p = 0.001)
Madrid (4/17) b
Portugal (3/41) Alto Douro (3/10)
France (1/4) Provence (1/1)
3 Spain (18/47) b Madrid (12/17) b 59 0.786 3.07 0.197 0.018 0.908 5 0.374
MON-1 Catalonia (3/3) (p = 0.004)
Majorca (3/12)
Portugal (38/41) Lisbon (25/25)
Alentejo (4/4)
Algarve (2/3) (Nr.3 = PT2(I))
Alto Douro (7/10)
France (2/4) Ce´rvennes (2/2)
Greece (1/16) Athens (1/8)
4 Spain (18) Madrid (12) 26 1.000 6.29 0.621 0.173 0.725 46 2.522
non-MON-1 Majorca (2) (p,0.001)
Andalucia (2)
Valencia (1)
unknown (1)
Portugal (2) Lisbon (1)
Alentejo (1)
France (3) Pyre´ne´es-Orientales (2)
unknown (1)
Italy (2) Sicily (1)
unknown (1)
Malta (1) unknown (1)
aThe two strains with mixed MON-1/non-MON-1 alleles (INF-32, PT2(I)) have been excluded. INF-35 (MON-108) is part of the MON-1 populations. In case of ES9(III) and
ES10(III) only the non-MON-1 genotype has been considered, as these strains have been identified as MON-24 by MLEE.
b3 strains from Madrid (ES1(I), ES3(I), ES6(I)) originally identified as MON-1 clearly group with the non-MON-1 population and have been considered as part of the non-
MON-1 population 4. The first number in the bracket indicates the number of strains from a given focus belonging to the respective population, the second one the
overall number of strains from a given focus. N, number of strains; P, proportion of polymorphic loci; MNA, mean number of alleles; Ho, observed heterozygosity; He,
expected heterozygosity; FIS, inbreeding coefficient; NAu, number of unique alleles; IA-Index of association.
doi:10.1371/journal.pntd.0000261.t007
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markers, which discriminate within this zymodeme [46], enabled
for the first time to reliably address key epidemiological questions
such as i) the existence of geographical subpopulations and the
extent of gene flow between them, ii) the impact of zoonotic and
anthroponotic transmission cycles, iii) the role of reservoir hosts
and vectors in sustaining genetic diversity, iv) comparison of
genetic diversity in immuno-competent and immuno-compro-
mised hosts, v) differential identification of re-infection or relapse
in treated patients, especially the immuno-compromised, vi) the
role of mutation and recombination in creating genetic diversity.
We detected considerable genetic structure within European
strains of L. infantum using model and distance-based analysis
methods. The main split between MON-1 and non-MON-1
strains observed in previous MLMT studies of however only few
strains of L. infantum [41,46] has been confirmed. Both studies had
suggested that both MON-1 and non-MON-1 strains each form a
monophyletic group, and are independent as are the other
populations of the L. donovani complex identified for L. donovani
strains from distinct geographical regions [41]. Monophyly of the
MON-1 group was also supported by recent studies based on
RFLP analysis of intergenic regions of cpb and gp63 [36], MLST
[63,64] and by a multifactorial genetic analysis of RFLP, MLMT,
MLST and sequence analysis of non-coding regions [65], which
however, all included only few MON-1 strains.
The non-MON-1 population was more diverse, with more
alleles, longer branches in the tree and a broader distribution of
the strains in FCA. This group may include several subpopula-
tions, perhaps consistent with different zymodeme groups and/or
geography. The position of two strains–INF-48 (Buck, Malta) and
INF-57 (ISS800, Italy, Sicily) was odd and could not be resolved
with confidence. In most studies using different genetic markers
they showed the most distant position among the whole L. infantum
cluster, at the basis of the non-MON-1 cluster right after the split
from the L. donovani strains [36,41,63,65]. A recent MLST study
[64] placed INF-48 and INF-57 close to the MON-1 cluster.
According to STRUCTURE in the present study, which does not
include L. donovani, both strains are members of the non-MON-1
group, INF-48 had, however, partial membership in MON-1. In
the distance tree INF-48 had a basal position within the MON-1
cluster, and INF-57 was a member of the non-MON-1 cluster.
The phylogenetic relationships of these strains and the structure of
the non-MON-1 group should be tested using a much larger set of
strains including as many zymodemes as possible.
The MON-1 cluster also included other zymodemes, which
must be closely related: MON-108, MON-77 and MON-98.
Indeed, these and MON-1, together with four other zymodemes
(MON-253, 27, 105, 72; not studied here), formed a distinct
subcluster in MLEE trees, with MON-1 as the putative original
zymodeme and the other zymodemes differing in the mobility of
only one isoenzyme (Malic enzyme-ME, glucose-6-phosphate
dehydrogenase–G6PD, NADH diaphorese-DIA, purine nucleo-
side phosphorylase 1-NP1, phosphoglucomutase-PGM, respec-
tively) [22]. Different enzymatic profiles might result from post-
translational modifications, as sequencing of ME which is
discriminating MON-1 and MON-98 did not reveal any
nucleotide differences between these zymodemes [63]. All other
20 zymodemes, 11 of which were studied here and assigned to the
non-MON-1 population by MLMT, differed in 2 to 4 enzymes.
Interestingly, all zymodymes of the non-MON-1 population share
the 104 phenotype for MDH (Malate dehydrogenase), in contrast
to zymodemes MON-1, MON-98, MON-77 and MON-108
forming our MON-1 population which share the 100 phenotype
for MDH. Similarly, for NP1, all members of the non-MON-1
population present the 130 or 140 phenotype, whereas strains of
the MON-1 population all present phenotype 100. Furthermore,
all zymodemes belonging to the MON-1 population were also
found in dogs, which is in favour of the proximity of these
zymodemes. Only few zymodemes of the non-MON-1 population,
MON-199, MON-34, and MON-11, have been occasionally
isolated from canines.
MLMT showed that MON-1 strains are not genetically
identical as previously suggested by MLEE and many different
genetic markers, but represent rather families of related clones.
The MON-1 group is indeed a more homogenous population than
the non-MON-1 group, and characterized by a low level of
heterozygosity. One could speculate that the predominance of
MON-1 and the lack of diversity are due to a quite recent
evolutionary history like a bottleneck followed by a rapid epidemic
spread. However, its wider spread when compared to other
zymodemes might be due to a better fitness and success in
infecting the canine host.
Using MLMT, we identified for the first time, geographic
substructures within MON-1 strains. Three clusters emerged from
this study: (i) Greece/Turkey/Israel/Tunisia, (ii) Spanish Baleares
islands and (iii) mainland Portugal and Spain. This observation has
important epidemiological implications, as it allows the estimation
of migration rates and provides a lacking biogeographical
perspective for control strategies.
Microsatellite markers allowed even differentiation of MON-1
strains between endemic foci within the same country. In Spain,
the majority of the strains from the mainland were genetically
separated from those isolated on the two Mediterranean islands,
which is most probably related to the existing geographical barrier.
Some strains from the mainland presented a genotype typical for
the islands and vice versa, which can be explained by the transfer of
parasites due to travel of infected persons or dogs. Analysing RFLP
of kDNA [37] concluded that L. infantum from Majorca constituted
a clonal population, though no mainland strains were included in
that study. Whether strains from Catalonia (the three analysed
herein grouped together in all distance trees) differ from other
mainland strains should be re-investigated with larger sample sizes.
In Portugal, no subclusters correlating with the four regions were
identified, which is congruent with a recent RFLP study on kDNA
[38]. These authors explain the lack of focus-specific genotypes by
the small size of the country and the frequent migration between
foci. According to our data, Alto Douro seems to be the most
divergent endemic focus in Portugal, followed by the Algarve. Seven
strains from Alto Douro, three human (PT8(I), PT8(II), PT10(I)),
two canine (PT13(II), PT14(II)) and two Phlebotomus ariasi isolates
(PT6(I) and PT7(I)), presented unique alleles for 8 of the 14 markers
used, in some cases identical to those found only in non-MON-1
strains, in other cases resembling the repeat range typical for non-
MON-1 strains and in three cases alleles were found exclusively in
Alto Douro. The human isolate PT8(II) had heterozygous loci
combining the specific Alto Douro alleles and the alleles typical for
all other strains of the mainland ES/PT population. Some of the
strains from this focus (PT8(I), PT7(I), PT8(II), PT13(II)) showed for
single loci alleles typical for non-MON-1.
The Greek MON-1 strains could not be further differentiated
regardless of whether they came from the Athens area or the island
of Crete. The strains from Turkey, Israel and the single strain from
North Africa (Tunisia) grouped with those from Greece but seem
to represent a distinct genotype. This needs, however to be
confirmed on a larger sample set from those regions.
Correlation with hosts and clinical manifestation
Two important interrelated epidemiological questions are the
impact of zoonotic and anthroponotic transmission cycles and the
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role of reservoir hosts and vectors in sustaining genetic diversity. In
our study no general relationships between MLMT genotypes,
host and reservoir were detected. Human and canine isolates were
present in all of the three main MON-1 populations. Moreover, in
all MON-1 groups cases of identical MLMT profiles were
identified for canine and human (immunocompetent and immu-
nocompromised) isolates, thus pointing to transmission of the same
parasite between humans and dogs, the domestic host. Such
groups of identical genotypes were found in each of three MON-1
populations. The single isolate from a fox, representing a sylvatic
host, did not show any special position within the MON-1 strains.
An interesting question is why only a single predominating
zymodeme is found in dogs–MON-1. We could, however observe
a considerable amount of diversity among the canine MON-1
isolates, even in such a small territory as Ibiza, where most of them
had different genotypes. A complete transmission cycle and the
vector status of P. ariasi was confirmed by detecting nearly identical
genotypes for human, canine and sand fly isolates from the Alto
Douro focus. Such complete transmission cycles were also shown
recently using kDNA PCR-RFLP [37,38].
Importantly, our data did not advocate for a correlation
between MLMT profile and clinical manifestation. VL was
present in all populations, whereas CL only in populations 3
(mainland Spain+Portugal) and 4 (non-MON-1). VL/HIV+ co-
infections were represented in all four populations and no special
cluster of VL/HIV+ strains was observed. This is in contrast to
reports from Spain [37,66] and Portugal [38], which found kDNA
PCR-RFLP patterns, which were associated with the immune
status (HIV+ immuno-compromised and immuno-competent) of
the patients. This has been attributed to the existence of
anthroponotic transmission cycles due to needle sharing among
drug users. Whether these contradictory results are caused by the
use of different DNA types, nuclear and kinetoplast minicircle
DNA, remains to be elucidated. By increasing K in STRUCTURE
analysis we observed in K = 5 a split of the non-MON-1
population, present also in the distance-based tree. Interestingly,
all newly described zymodemes, found exclusively in HIV+/
leishmaniasis co-infections [9,30,67] are members of the same
subgroup. We also found that the majority of strains with these
zymodemes were heterozygous suggesting a relationship between
anthroponotic syringe transmission cycles and recombination
events.
Detection of relapses and re-infections
Identical MLMT genotypes were found for strains isolated from
different episodes in 10 out of the 12 relapse cases. For the two
cases presenting different MLMT profiles in the respective
episodes it is possible that the first infection was due to two
strains, of which one has been eliminated during the first curse of
treatment. Another possibility is re-infection with a new strain.
Because microsatellite markers did not detect an individual
MLMT fingerprint for each strain, re-infection can only be
detected if strains from successive episodes have different
genotypes. Otherwise, de-novo infection with an identical genotype
circulating in the same focus cannot be excluded. RFLP analysis of
minicircle kDNA has been successfully applied for monitoring VL
outbreaks among intra-venous drug users and for differentiation
between relapses and re-infections [13,14]. However, because of
the multicopy nature of minicircle kDNA, the RFLP profiles are
very complex, difficult to interpret and problematic for inter-
laboratory comparisons. The stability of the pattern in the course
of treatment is also still under question. Microsatellite marker
stability during long term cultivation and animal passages has been
confirmed (data not shown). Nevertheless, MLMT and kDNA
PCR-RFLP are the most discriminative methods available to date
for strain fingerprinting [42].
Gene flow and recombination
In this study, some amount of gene flow was detected between
and within all four populations. This became evident in the
STRUCTURE plots where some strains could not be clearly
assigned and had membership coefficients for more than one
population and was attributed to the presence of alleles typical for
more than one population either in homozygous or heterozygous
combinations in single strains.
Inbreeding coefficients and indices of association as a measure
of multilocus linkage disequilibrium (LD) pointed to a predomi-
nantly clonal propagation particularly of all populations found for
MON-1, but also the non-MON-1 population, as previously
suggested [68–72]. However, it does not rule out the possibility of
occasional genetic recombination, as supported here by the
occurrence of strains of potential mosaic and heterozygous
genotypes, even between MON-1 and non-MON-1 populations.
Two explanations are likely: (1) mixed infections, (2) hybrid
strains/recombination. No indications for aneuploidy or polyploi-
dy, asexual mechanisms leading to genetic polymorphism during
reversion to the normal ploidy and having been described to occur
in Leishmania [73], were obtained in our study.
By using highly discriminatory markers on 141 strains of L.
infantum, among them 119 MON-1 strains, we tried to minimize
the impact of statistical type II errors (too few strains, poorly
discriminating markers) which probably have led to underestima-
tion of recombination events in Leishmania in previous studies, as
was suggested among others by Tibayrenc [69,74].
Significantly, all three sand fly isolates but only five of the many
human isolates and a single canine isolate were of mixed ancestry.
Whilst the Phlebotomus perniciosus isolate PT(II)2 had for most of the
markers alleles characteristic for both, MON-1 and non-MON-1,
in the second sand fly isolate PT7(I), the canine strain PT13(II) and
the human isolates PT8(II) and PT8(I) MON-1 type alleles
dominated. Furthermore, the two sand fly isolates from Alto
Douro PT7(I) and PT6(I) had a unique allele for marker Li 22–35
that differed significantly from the usual MON-1 alleles and rather
resembled the range of non-MON-1 alleles.
Leishmania hybrids have been reported in the literature, even in
cloned parasites [75–79]. The mechanisms underlying hybrid
formation are, however still unknown. The observation of a higher
number of putative recombinant genotypes in the vector could
suggest that recombination occurs in the vector. Alternatively,
vectors could transmit strains that are infective, but normally do
not cause disease and that are, therefore, not isolated from the
vertebrate host. Preliminary data on sand fly isolates indicate that
vectors might play a role in sustaining genetic diversity.
Mixed infections as a basis for recombination events are also
conceivable in HIV patients, especially when parasites are transmit-
ted by needle sharing [79]. That most of the new L. infantum
zymodemes, almost exclusively detected in HIV co-infected patients
[9,24,30,37,67,80], are heterozygous favours this hypothesis. Recent-
ly, a substantial number of heterozygous sites and mosaic genotypes
were identified in strains of L. donovani and L. infantum [64]. These
authors concluded that genetic exchange would be the most plausible
explanation for their data and that the importance of recombination
events in Leishmania has been underestimated so far, which is
supported by the present MLMT data.
Conclusions
In the present study, for the first time several epidemiological
questions linked with the MON-1 zymodeme could be addressed
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using fast evolving microsatellites. These markers are hypervari-
able, genetically neutral and co-dominant and are therefore ideal
to detect fine scale and recent genetic structure. Last but not least,
the analyses could be performed directly from biological material
with a high throughput. The results obtained in different
laboratories are comparable and can be stored in a database.
For a comprehensive understanding of L. infantum epidemiology
strains from all endemic foci around the Mediterranean have to be
studied, and a good sampling strategy has to be applied (e.g. more
sand fly isolates, other viscerotropic and dermotropic zymodemes,
study of foci with significant enzymatic polymorphism etc.). The
basis for such a study is the present work, which can now be
completed by the data of all those mentioned strains.
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